Evommune (EVMN) EPS (Basic) (2024 - 2026)
Evommune's (EVMN) quarterly EPS (Basic) came in at -$3.38 in Q1 2026, up 64.56% year-on-year from -$2.05 in Q1 2025, and up 25.71% on a QoQ basis from -$4.54 in Q4 2025.
Evommune (EVMN) EPS (Basic) (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of EPS (Basic) data on file, last reported at -$3.38 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 64.56% year-over-year to -$3.38 in Q1 2026; TTM through Mar 2026 was -$5.01, a N/A change from a year earlier, with the FY2025 full-year figure at -$21.55, up 51.89% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$3.38, up from -$4.54 in the prior quarter.
- Over the last five years, EPS (Basic) for EVMN reached as high as -$3.38 in Q1 2026 and fell as low as -$13.37 in Q4 2024.
- Historically, EPS (Basic) has averaged -$8.23 across 3 years, with a median of -$8.8 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 66.02% in 2025 and fell as far as 22.85% in 2025.
- Year by year, EPS (Basic) stood at -$13.37 in 2024, then soared by 66.02% to -$4.54 in 2025, then increased by 25.71% to -$3.38 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$3.38 in Q1 2026, -$4.54 in Q4 2025, and -$8.07 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Evommune | 380.30 Mn | 168.84 Mn | - | -3.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.38 |
| Dec 31, 2025 | -4.54 |
| Sep 30, 2025 | -8.07 |
| Mar 31, 2025 | -9.52 |
| Dec 31, 2024 | -13.37 |
| Sep 30, 2024 | -10.47 |